Trials / Conditions / Hematopoietic Cell Transplantation Recipient

Hematopoietic Cell Transplantation Recipient

19 registered clinical trials studyying Hematopoietic Cell Transplantation Recipient — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	The Effect of an Online ACT Intervention on Meaning-Making Process in Cancer Patients Following Hematopoietic NCT06266182	University of Social Sciences and Humanities, Warsaw	N/A
Terminated	Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malig NCT03272633	Rutgers, The State University of New Jersey	EARLY_Phase 1
Withdrawn	Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant NCT03531281	City of Hope Medical Center	Phase 1
Withdrawn	Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Bloo NCT03438344	City of Hope Medical Center	Phase 2
Completed	Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participa NCT03583424	Ohio State University Comprehensive Cancer Center	Phase 1 / Phase 2
Withdrawn	Study of Personalized Melphalan Dosing in the Setting of Autologous Transplant NCT03328936	Ohio State University Comprehensive Cancer Center	Phase 2
Completed	SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart NCT03574012	Fred Hutchinson Cancer Center	N/A
Suspended	Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treatin NCT03494569	City of Hope Medical Center	Phase 1
Completed	Positive Psychology Intervention to Improve Quality of Life in Stem Cell Transplant Survivors and Their Caregi NCT03525106	Fred Hutchinson Cancer Center	N/A
Completed	Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transpla NCT03267186	Andrew Rezvani	Phase 2
Terminated	Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant NCT03102060	Rutgers, The State University of New Jersey	N/A
Terminated	Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia NCT03195010	Fred Hutchinson Cancer Center	Phase 2
Completed	High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant NCT02860039	Vanderbilt-Ingram Cancer Center	Phase 2
Active Not Recruiting	Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myel NCT02420860	M.D. Anderson Cancer Center	Phase 2
Completed	Eltrombopag Olamine in Increasing Platelet Counts in Patients Undergoing Transplant NCT01927731	M.D. Anderson Cancer Center	Phase 2
Completed	Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multipl NCT01718743	M.D. Anderson Cancer Center	Phase 2
Completed	Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients Wi NCT01701986	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Active Not Recruiting	Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies NCT00736749	Children's Oncology Group	—
Available	Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Partic NCT03626285	OHSU Knight Cancer Institute	—